NasdaqGS - Nasdaq Real Time Price USD

HealthEquity, Inc. (HQY)

82.32 +0.64 (+0.78%)
As of 10:35 AM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
1/31/2024
1/31/2023
1/31/2022
1/31/2021
1/31/2020
Total Revenue
999,587.00
999,587.00
861,748.00
756,556.00
733,570.00
--
Cost of Revenue
376,950.00
376,950.00
369,813.00
331,791.00
318,236.00
--
Gross Profit
622,637.00
622,637.00
491,935.00
424,765.00
415,334.00
--
Operating Expense
494,503.00
494,503.00
454,282.00
384,198.00
335,330.00
--
Operating Income
128,134.00
128,134.00
37,653.00
40,567.00
80,004.00
--
Net Non Operating Interest Income Expense
-43,317.00
-43,317.00
-46,661.00
-35,071.00
-33,836.00
--
Other Income Expense
-9,777.00
-9,777.00
-29,088.00
-72,237.00
-42,028.00
--
Pretax Income
75,040.00
75,040.00
-38,096.00
-66,741.00
4,140.00
--
Tax Provision
19,328.00
19,328.00
-11,953.00
-22,452.00
-4,694.00
--
Net Income Common Stockholders
55,712.00
55,712.00
-26,143.00
-44,289.00
8,834.00
--
Diluted NI Available to Com Stockholders
55,712.00
55,712.00
-26,143.00
-44,289.00
8,834.00
--
Basic EPS
0.65
0.65
-0.31
-0.53
0.12
--
Diluted EPS
0.64
0.64
-0.31
-0.53
0.12
--
Basic Average Shares
85,564.00
85,564.00
84,442.00
83,133.00
74,235.00
--
Diluted Average Shares
86,957.00
86,957.00
84,442.00
83,133.00
75,679.00
--
Total Operating Income as Reported
117,699.00
117,699.00
9,057.00
-24,238.00
34,014.00
--
Total Expenses
871,453.00
871,453.00
824,095.00
715,989.00
653,566.00
--
Net Income from Continuing & Discontinued Operation
55,712.00
55,712.00
-26,143.00
-44,289.00
8,834.00
--
Normalized Income
63,454.77
63,454.77
-6,489.79
4,810.48
43,222.84
--
Interest Income
12,138.00
12,138.00
1,763.00
1,501.00
1,045.00
--
Interest Expense
55,455.00
55,455.00
48,424.00
36,572.00
34,881.00
--
Net Interest Income
-43,317.00
-43,317.00
-46,661.00
-35,071.00
-33,836.00
--
EBIT
130,495.00
130,495.00
10,328.00
-30,169.00
39,021.00
--
EBITDA
283,573.00
283,573.00
171,529.00
107,019.00
154,925.00
--
Reconciled Cost of Revenue
316,635.00
316,635.00
303,198.00
277,394.00
278,396.00
--
Reconciled Depreciation
153,078.00
153,078.00
161,201.00
137,188.00
115,904.00
--
Net Income from Continuing Operation Net Minority Interest
55,712.00
55,712.00
-26,143.00
-44,289.00
8,834.00
--
Total Unusual Items Excluding Goodwill
-10,435.00
-10,435.00
-28,649.00
-73,945.00
-47,108.00
--
Total Unusual Items
-10,435.00
-10,435.00
-28,649.00
-73,945.00
-47,108.00
--
Normalized EBITDA
294,008.00
294,008.00
200,178.00
180,964.00
202,033.00
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
Tax Effect of Unusual Items
-2,692.23
-2,692.23
-8,995.79
-24,845.52
-12,719.16
--
1/31/2020 - 7/31/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PHR Phreesia, Inc.
18.74
-0.95%
 
RQHTF Reliq Health Technologies Inc.
0.1000
-16.67%
 
NHIQ NantHealth, Inc.
1.2000
+4.35%
 
PGNY Progyny, Inc.
27.73
+2.88%
 
SLP Simulations Plus, Inc.
47.10
-2.36%
 
PRVA Privia Health Group, Inc.
17.49
+0.69%
 
OMCL Omnicell, Inc.
32.38
-0.66%
 
EVH Evolent Health, Inc.
21.40
+0.99%
 
BTSG BrightSpring Health Services, Inc.
11.31
+0.53%
 
PBSV Pharma-Bio Serv, Inc.
0.6480
-7.42%